Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Stonebridge Ventures is a prominent venture capital firm founded in 2010 and headquartered in Seoul, South Korea. With a mission to support entrepreneurs with bold ideas, the firm focuses on fostering innovation and growth across various industries. Stonebridge Ventures has established itself as a key player in the venture capital landscape, particularly in the technology and life sciences sectors. The firm invests across all stages of growth, from pre-seed and seed investments to late-stage funding, including Series A through E and growth equity. This comprehensive approach allows them to engage with startups at different points in their development, providing tailored support to help them scale effectively.
With a strong emphasis on professional support and strategic connections, Stonebridge Ventures aims to facilitate the growth of its portfolio companies. The firm has built a reputation for identifying and nurturing market leaders, leveraging its extensive network and industry expertise to drive success. As a result, Stonebridge Ventures has attracted a diverse base of limited partners (LPs) who share its vision of fostering innovation in Asia's dynamic startup ecosystem.
Stonebridge Ventures specializes in investing in the technology and life sciences sectors, with a keen interest in companies that demonstrate innovative ideas and cutting-edge technologies. The firm is particularly focused on supporting entrepreneurs who are poised to disrupt traditional markets and create new opportunities for growth. By investing across all stages of development, from pre-seed to late-stage funding, Stonebridge Ventures ensures that it can provide the necessary resources and guidance to help startups thrive.
The firm seeks out companies that are not only technologically advanced but also have the potential to become market leaders in their respective fields. This includes a strong emphasis on healthcare and biotech, where Stonebridge Ventures believes that innovation can lead to significant advancements in patient care and treatment options. The firm typically invests in companies that are developing groundbreaking solutions, such as AI-driven technologies, novel drug therapies, and advanced medical devices.
In terms of investment size, Stonebridge Ventures is flexible, adapting its check sizes to the specific needs of the companies it supports. This approach allows the firm to engage with a wide range of startups, from early-stage ventures seeking initial funding to more established companies looking for growth equity. Overall, Stonebridge Ventures is committed to fostering innovation and supporting the next generation of leaders in the technology and life sciences sectors.
Stonebridge Ventures boasts a diverse and impressive portfolio of companies that exemplify its commitment to innovation in technology and life sciences. Notable investments include **Nearslab**, which specializes in AI model optimization and lightweight solutions, and **S2W**, a provider of AI security solutions often compared to industry leader Palantir. Another significant investment is **Onconic Therapeutics**, a company focused on the development of new drugs aimed at addressing unmet medical needs.
Additionally, Stonebridge Ventures has invested in **OpenEdge**, which develops AI semiconductors, and **ReevesMed**, recognized for creating the world's first single-use multi-joint laparoscopic surgical instruments. These companies not only highlight the firm's focus on cutting-edge technology but also its dedication to supporting advancements that can have a profound impact on healthcare and industry.
With a portfolio that spans various stages of growth, Stonebridge Ventures continues to seek out innovative startups that align with its investment thesis. The firm’s strategic approach to portfolio management ensures that it provides the necessary support and resources to help its companies achieve their full potential.
To pitch Stonebridge Ventures, please email your proposal to info@stonebridge.co.kr. They welcome pitches from entrepreneurs at various stages and encourage clear communication of your business model and growth strategy.
Stonebridge Ventures invests across a wide range of stages, including pre-seed, seed, Series A, Series B, Series C, Series D, Series E, and growth equity. This comprehensive approach allows them to support companies at various points in their development.
Founders interested in pitching Stonebridge Ventures can reach out via email at info@stonebridge.co.kr. It is advisable to provide a clear and concise overview of your business, including your value proposition, market opportunity, and growth strategy.
Stonebridge Ventures primarily focuses on the technology and life sciences sectors. They are particularly interested in companies that are developing innovative solutions in healthcare and biotech, as well as those leveraging advanced technologies.
While specific check sizes can vary depending on the stage and needs of the company, Stonebridge Ventures is known for being flexible and adapting its investments to support startups effectively at different growth stages.
Stonebridge Ventures has a geographic focus primarily in Asia, where it seeks to engage with innovative companies that are poised for growth in the technology and life sciences sectors.
The application process involves reaching out via email to info@stonebridge.co.kr. Founders should prepare a detailed pitch that outlines their business model, market potential, and how they align with the firm’s investment focus.
Stonebridge Ventures emphasizes providing professional support and connections to its portfolio companies. This includes strategic guidance, mentorship, and access to a network of industry experts to facilitate growth and success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.